Fit For Function Program
OtherA 12-week YMCA-based wellness program for persons with stroke, consisting of 2 group exercise sessions, one gym exercise session and one education session per week with trained instructors
NCT Number: NCT02703805
Building on an earlier pilot study, this randomized controlled trial will compare the effectiveness of a 12 week community YMCA-based wellness program specifically designed for people with stroke (Fit for Function) to a standard YMCA membership.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
The Brantford Family YMCA, Brantford, Ontario, Canada
The program will be delivered through a partnership between McMaster University, the YMCA and Hamilton Health Sciences/ the Brant Community Healthcare System/ the Niagara Health System. Participants will exercise three times a week and receive weekly education about how to take care of themselves after a stroke. The YMCA staff who deliver the program will have specialized training about how to help people with a stroke exercise safely and effectively. The hospital within each region will provide specialized on-site physiotherapy consultative support. The comparator standard YMCA membership will include typical sessions with a wellness coach who has basic safety training regarding stroke and exercise.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A 12-week YMCA-based wellness program for persons with stroke, consisting of 2 group exercise sessions, one gym exercise session and one education session per week with trained instructors
A 12 week standard YMCA membership.
Time frame: baseline, 12 weeks, 24 weeks
This measure assesses the degree to which individuals who have experienced traumatic or incapacitating illness achieve reintegration into normal social activities.
Time frame: baseline, 12 weeks, 24 weeks
This is a 9-item measure that assesses frequency and intensity of aerobic physical activity and frequency of strengthening and flexibility exercises.
Time frame: baseline, 12 weeks, 24 weeks
This test is used to quantify lower extremity function by evaluating the time to walk 8 feet, standing balance and repeated chair stands.
Time frame: baseline, 12 weeks, 24 weeks
This test is an indicator of exercise capacity and measures the distance walked in 6 minutes.
Time frame: baseline, 12 weeks, 24 weeks
Hand-held dynamometry will measure the average strength of three trials.
Time frame: baseline, 12 weeks, 24 weeks
This is a generic utility-based health related quality of life questionnaire.
Time frame: baseline, 12 weeks, 24 weeks
This is a 13-item measure of the patient's level of knowledge, skill and confidence for self-management.
Time frame: baseline, 12 weeks, 24 weeks
The BMI will be calculated from measurements of body mass and height as an indicator of cardiovascular health.
Time frame: baseline, 12 weeks, 24 weeks
12 hour fasting levels of lipids will be used as an indicator of cardiovascular health.
Time frame: baseline, 12 weeks, 24 weeks
12 hour fasting levels of glucose in blood will be used as an indicator of cardiovascular health.
Time frame: baseline, 12 weeks, 24 weeks
12 hour fasting levels of inflammatory markers in blood will be used as an indicator of cardiovascular health.
Time frame: 0- 24 weeks
An indicator of healthcare resource utilization (hospitalizations, medical appointments and investigations, medication use) for economic analysis.
McMaster University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05477238
Behavior, Brain Diseases
Limoges, France
View Trial DetailsNCT03448159
Behavior, Brain Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT01864382
Behavior, Brain Diseases
Barcelona, Catalonia, Spain
View Trial DetailsNCT01915368
Behavior, Brain Diseases
Calgary, Alberta, Canada
View Trial Details